C07K 16/16
Against material from plants
Official title: against material from plants
C07K16/16 (Against material from plants) appears on 249 US grants and 306 published applications in this corpus.
Search patents in C07K- Granted patents
- 249
- Published applications
- 306
- Assignees
- 199
- Inventors
- 748
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 5 | 0 |
| 1997 | 8 | 0 |
| 1998 | 15 | 0 |
| 1999 | 7 | 0 |
| 2000 | 8 | 0 |
| 2001 | 11 | 1 |
| 2002 | 10 | 6 |
| 2003 | 2 | 17 |
| 2004 | 4 | 4 |
| 2005 | 3 | 11 |
| 2006 | 7 | 8 |
| 2007 | 4 | 8 |
| 2008 | 4 | 7 |
| 2009 | 2 | 10 |
| 2010 | 3 | 13 |
| 2011 | 11 | 13 |
| 2012 | 1 | 13 |
| 2013 | 14 | 17 |
| 2014 | 12 | 22 |
| 2015 | 11 | 16 |
| 2016 | 14 | 20 |
| 2017 | 11 | 18 |
| 2018 | 9 | 15 |
| 2019 | 10 | 13 |
| 2020 | 10 | 6 |
| 2021 | 5 | 15 |
| 2022 | 7 | 12 |
| 2023 | 9 | 7 |
| 2024 | 6 | 16 |
| 2025 | 8 | 11 |
| 2026 | 7 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Engineered immune cells to target SARS-CoV228 Jul 2026US 12,691,146 B2The Johns Hopkins University
- Antigen binding proteins which bind to the pMHC HLA-DQ2.5:DQ2.5 presenting a gliadin peptide21 Apr 2026US 12,606,626 B2Universitetet I Oslo
- Means and methods for detecting soy allergens7 Apr 2026US 12,596,111 B2Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V.
- Brassica GAT event and compositions and methods for the identification and/or detection thereof31 Mar 2026US 12,590,341 B2Pioneer Hi-Bred International, Inc.
- Methods of treating allergy using anti-bet v 1 antibodies24 Mar 2026US 12,583,914 B2Regeneron Pharmaceuticals, Inc.
- Anti-allergen antibodies and uses thereof1 Oct 2026US 2026/0297169 A1
- Method for degrading target protein20 Aug 2026US 2026/0242452 A1Inter-University Research Institute Corporation Research Organization of Information and Systems
- Methods of Using Formulations for Disrupting or Destroying Pathogens18 Jun 2026US 2026/0167700 A1
- Composition comprising anti-gliadin antibodies and method of use thereof to detect gliadin in a sample28 May 2026US 2026/0146080 A1NIMA Partners, Inc.
- Camptothecin derivative for treating or preventing cancer and antibody-drug conjugate thereof16 Apr 2026US 2026/0102507 A1Chengdu Brilliant Pharmaceutical Co., Ltd.
Most cited
By later US patents
- Monoclonal antibodies and detection methods for phosphinothricin-N-acetyl-transferase enzyme640US 9,371,394 B2Dow AgroSciences LLC · 2016
- High affinity human antibodies and human antibodies against digoxin211US 6,255,458 B1GenPharm International, Inc. · 2001
- Antibody selection methods using cell surface expressed libraries78US 5,866,344 ABoard of Regents, The University of Texas System · 1999
- Cytoplasmic bacteriophage display system60US 5,766,905 AAssociated Universities, Inc. · 1998
- Cellular and serum protein anchors for modulating pharmacokinetics53US 5,843,440 ARedCell, Canada, Inc. · 1998